Mommox (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mommox, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in both adults and children by reducing inflammation of the nasal mucosa, alleviating congestion, itching, sneezing and helping shrink polyps.

GNH USA supplies Mommox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and offering reliable global distribution.

Mommox (mometasone furoate) is a topical corticosteroid that acts on inflammatory processes of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. Nasal polyps: decreases polyp size and improves nasal airflow. Seasonal allergic rhinitis: provides symptom relief during pollen seasons.

Mommox may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal cavity

When prescribing Mommox, clinicians should consider several safety precautions to minimize risks.

Pregnancy: consult a healthcare provider as safety data are limited. Children: use only under medical supervision. Recent nasal surgery: avoid use shortly before or after the procedure. Concurrent systemic corticosteroids: monitor for additive systemic effects. Avoid spray contact with eyes. Store at room temperature: keep in original container, protect from moisture and heat.

Mommox can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase systemic exposure. - Potent immunosuppressants: additive immunosuppression risk. - Live vaccines: reduced efficacy and increased infection risk.

Moderate Interactions (Monitor Closely): - Other intranasal corticosteroids: risk of excess local effects. - Antifungal azoles (e.g., ketoconazole): may raise mometasone levels. - Ritonavir or other protease inhibitors: potential increase in exposure.